Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-19.43	681.59	-845.97
Graham Fair Price	-9.31	23371.58	25770.01
PEG	161.67	-0.54	0.21
Price/Book	-18.28	9.48	11.60
Price/Cash Flow	1249.11	1156.23	-85.70
Prices/Earnings	5.20	95.21	-90.51
Price/Sales	-15.36	20.13	23.78
Price/FCF	1249.11	1156.23	-85.70
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	792.42	0.09	< 0.005
Operating Margin	-48.22	0.03	-0.06
ROA	-27.87	< 0.005	-0.01
ROE	-0.03	0.02	-22.32
ROIC	< 0.005	0.01	39.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.01	683.05
Dividends QOQ	-0.93	-1.00	-7.18
EBIT QOQ	-2.98	1.51	-49.24
EPS QOQ	-4.37	1.76	-59.80
FCF QOQ	-0.27	1.06	287.93
Revenue QOQ	-0.11	< 0.005	94.05
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.32	61.83	-13.31
Days Sales Outstanding (DSO)	62.30	61.58	-1.15
Inventory Turnover	1.26	1.46	15.36
Debt/Capitalization	0.55	0.57	2.41
Quick Ratio	1.02	0.89	-12.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	30356.86	31236.50	2.90
Cash	8142.10	11618.15	42.69
Capex	-6272.60	-4171.87	33.49
Free Cash Flow	-4107.22	256.00	-93.77
Revenue	14800.42	14704.61	-0.65
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.73	1.33	-22.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-74.66	76.90	3.00
Naive Interpretation	Member

06 - Financial Health · Weak

Rating